S2Medical revises timeline for rights issue
The rights issue is conducted in units of ten shares due to Euroclear's two-decimal limit, and the record date is moved to August 20, 2026.
See the latest news and media coverage for S2Medical. We track all announcements, press releases, and industry mentions in real time, all in one place.
Wound healing biomed-tech innovator
s2m.seLast updated
In short: S2Medical strengthened its financial position through share issues and secured a key European patent for its antimicrobial technology.
The rights issue is conducted in units of ten shares due to Euroclear's two-decimal limit, and the record date is moved to August 20, 2026.
S2Medicals' ownership stake of 22.3 percent was already fully written down, which means no financial impact.
Subscribed by SivlerSkog Group AB at 0.0055 SEK per share.
The board was re-elected, the articles of association were amended. A directed issue to SilverSkog Group and a rights issue were decided.
S2Medical's stock is listed on the Stockholm Stock Exchange in Sweden. What is S2Medical's stock symbol? S2Medical's stock symbol is "S2ME." What is S2Medical's market capitalization? As of today, S2Medical's market capitalization is 453,000,000. S2Medical's earnings per share ...
* S2MEDICAL AB (PUBL) HAS RECEIVED A RECORD ORDER FOR MEDICAL CONSUMABLES INTENDED TO COUNTER THE SPREAD OF COVID-19 * S2MEDICAL AB (PUBL) - ORDER...
S2Medical AB (publ) has received a new order for medical consumables intended to counteract the spread of COVID-19. The order value is approx 3 700 000 SEK with...
Stockholm, November 28, 2018— Nasdaq (Nasdaq: NDAQ) announces that the trading in S2Medical AB's shares (short name: S2M) will commence today on Nasdaq First North...
Track S2Medical and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Discover what's making headlines across other trending companies.